Published 6 issues per year
ISSN Print: 1040-8401
ISSN Online: 2162-6472
Indexed in
Regulatory Roles of the Tumor Necrosis Factor Receptor BCMA
ABSTRACT
B cell maturation antigen (BCMA) is a tumor necrosis family receptor (TNFR) member that is predominantly expressed on terminally differentiated B cells and, upon binding to its ligands B cell activator of the TNF family (BAFF) and a proliferation inducing ligand (APRIL), delivers pro-survival cell signals. Thus, BCMA is mostly known for its functional activity in mediating the survival of plasma cells that maintain long-term humoral immunity. The expression of BCMA has also been linked to a number of cancers, autoimmune disorders, and infectious diseases that suggest additional roles for BCMA activity. Despite recent advances in our understanding of the roles for the related TNFR members BAFF-R and transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI), the signaling pathway used by BCMA for mediating plasma cell survival as well as its putative function in certain disease states are not well understood. By examining the expression, regulation, and signaling targets of BCMA, we may gain further insight into this receptor and how it operates within cells in both health and disease. This information is important for identifying new therapeutic targets that may be relevant in treating diseases that involve the BAFF/APRIL cytokine network.
-
Luu Van Phi, Hevezi Peter, Vences-Catalan Felipe, Maravillas-Montero José Luis, White Clayton Alexander, Casali Paolo, Llorente Luis, Jakez-Ocampo Juan, Lima Guadalupe, Vilches-Cisneros Natalia, Flores-Gutiérrez Juan Pablo, Santos-Argumedo Leopoldo, Zlotnik Albert, TSPAN33 is a novel marker of activated and malignant B cells, Clinical Immunology, 149, 3, 2013. Crossref
-
El-Komy Mohamed H.M., Tawfik Shereen O., Shaker Olfat G., Expression of the B-cell maturation antigen and a proliferation-inducing ligand in psoriatic plaques, Journal of the Egyptian Womenʼs Dermatologic Society, 11, 1, 2014. Crossref
-
Mueller Antje, Brieske Christoph, Schinke Susanne, Csernok Elena, Gross Wolfgang L, Hasselbacher Katrin, Voswinkel Jan, Holl-Ulrich Konstanze, Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis, Arthritis Research & Therapy, 16, 1, 2014. Crossref
-
Goenka Radhika, Scholz Jean L., Sindhava Vishal J., Cancro Michael P., New roles for the BLyS/BAFF family in antigen-experienced B cell niches, Cytokine & Growth Factor Reviews, 25, 2, 2014. Crossref
-
Coquery Christine M., Loo William M., Wade Nekeithia S., Bederman Annelise G., Tung Kenneth S., Lewis Janet E., Hess Henry, Erickson Loren D., BAFF Regulates Follicular Helper T Cells and Affects Their Accumulation and Interferon-γ Production in Autoimmunity, Arthritis & Rheumatology, 67, 3, 2015. Crossref
-
Wei Fang, Xu Shu, Jia Xiaoyi, Sun Xiaojing, Yang Xuezhi, Wei Wei, Chang Yan, BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats, International Immunopharmacology, 31, 2016. Crossref
-
Wei Fang, Chang Yan, Wei Wei, The role of BAFF in the progression of rheumatoid arthritis, Cytokine, 76, 2, 2015. Crossref
-
Saxena R., Bjonnes A.C., Georgopoulos N.A., Koika V., Panidis D., Welt C.K., Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume, Human Reproduction, 30, 7, 2015. Crossref
-
Jasek M., Wagner M., Sobczynski M., Wolowiec D., Kuliczkowski K., Woszczyk D., Kielbinski M., Kusnierczyk P., Frydecka I., Karabon L., Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL - a preliminary study on a Polish population, Tissue Antigens, 86, 4, 2015. Crossref
-
Matsuda Yoshiko, Haneda Masataka, Kadomatsu Kenji, Kobayashi Takaaki, A proliferation-inducing ligand sustains the proliferation of human naïve (CD27−) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen, Cellular Immunology, 295, 2, 2015. Crossref
-
Higdon Lauren E., Scholz Jean L., Cancro Michael P., BAFF and B Cell Development, Homeostasis, and Selection, in Encyclopedia of Immunobiology, 2016. Crossref
-
Ehrenstein Michael R., Wing Charlotte, The BAFFling effects of rituximab in lupus: danger ahead?, Nature Reviews Rheumatology, 12, 6, 2016. Crossref
-
Hou Weihua, Meng Xianchao, Wang Yuxiong, Mo Wei, Wu Yi, Yu Min, Characterization and high-yield production of non-N-glycosylated recombinant human BCMA-Fc inPichia pastoris, Engineering in Life Sciences, 17, 2, 2017. Crossref
-
Zhang Feng, Song Shan-shan, Shu Jin-ling, Li Ying, Wu Yu-jing, Wang Qing-tong, Chen Jing-yu, Chang Yan, Wu Hua-xun, Zhang Ling-ling, Wei Wei, BAFF upregulates CD28/B7 and CD40/CD154 expression and promotes mouse T and B cell interaction in vitro via BAFF receptor, Acta Pharmacologica Sinica, 37, 8, 2016. Crossref
-
Mosley Yung-Yi C., HogenEsch Harm, Selection of a suitable reference gene for quantitative gene expression in mouse lymph nodes after vaccination, BMC Research Notes, 10, 1, 2017. Crossref
-
Matsuda Yoshiko, Imamura Ryoichi, Takahara Shiro, Evaluation of Antigen-Specific IgM and IgG Production during an In Vitro Peripheral Blood Mononuclear Cell Culture Assay, Frontiers in Immunology, 8, 2017. Crossref
-
Lang Julie, Zhang Bicheng, Kelly Margot, Peterson Jacob N., Barbee Jacob, Freed Brian M., Di Santo James P., Matsuda Jennifer L., Torres Raul M., Pelanda Roberta, Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice, Blood Advances, 1, 27, 2017. Crossref
-
Myles Arpita, Scholz Jean L., Cancro Michael P., BAFF/BLyS Family, in Encyclopedia of Signaling Molecules, 2018. Crossref
-
Ansari Mahbubeh, Yazdani Reza, Sherkat Roya, Homayouni Vida, Ganjalikhani-Hakemi Mazdak, Rezaei Abbas, Decreased Expression of B cell Maturation Antigen in Patients with Common Variable Immunodeficiency, Pediatric Allergy, Immunology, and Pulmonology, 30, 1, 2017. Crossref
-
Myles Arpita, Scholz Jean L., Cancro Michael P., BAFF/BLyS Family, in Encyclopedia of Signaling Molecules, 2016. Crossref
-
Bishop Gail A., Stunz Laura L., Hostager Bruce S., TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation, Frontiers in Immunology, 9, 2018. Crossref
-
Schmidts Andrea, Ormhøj Maria, Choi Bryan D., Taylor Allison O., Bouffard Amanda A., Scarfò Irene, Larson Rebecca C., Frigault Matthew J., Gallagher Kathleen, Castano Ana P., Riley Lauren S., Cabral Maria L., Boroughs Angela C., Velasco Cárdenas Rubí M.-H., Schamel Wolfgang, Zhou Jing, Mackay Sean, Tai Yu-Tzu, Anderson Kenneth C., Maus Marcela V., Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma, Blood Advances, 3, 21, 2019. Crossref
-
Trigos Anna S, Pearson Richard B, Papenfuss Anthony T, Goode David L, Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer, eLife, 8, 2019. Crossref
-
Jackson Shaun W, Davidson Anne, BAFF inhibition in SLE—Is tolerance restored?, Immunological Reviews, 292, 1, 2019. Crossref
-
Dawood Lamees M., Elshabacy Fatemah A., Ghanem Heba B., B-Cell Activating Factor (BAFF) and Its Receptors in Systemic Lupus Erythematosus, Rheumatoid Arthritis, SSRN Electronic Journal, 2018. Crossref
-
Maglione Paul J., Ko Huaibin M., Tokuyama Minami, Gyimesi Gavin, Soof Camilia, Li Mingjie, Sanchez Eric, Chen Haiming, Radigan Lin, Berenson James, Cunningham-Rundles Charlotte, Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies, The Journal of Allergy and Clinical Immunology: In Practice, 8, 1, 2020. Crossref
-
Bae Jooeun, Parayath Neha, Ma Wenxue, Amiji Mansoor, Munshi Nikhil, Anderson Kenneth C., BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications, Leukemia, 34, 1, 2020. Crossref
-
Bae Jooeun, Samur Mehmet, Richardson Paul, Munshi Nikhil C., Anderson Kenneth C., Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy, Leukemia, 33, 9, 2019. Crossref
-
Nguyen Doan C., Joyner Chester J., Sanz Iñaki, Lee F. Eun-Hyung, Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells, Frontiers in Immunology, 10, 2019. Crossref
-
Giuliani Nicola, Accardi Fabrizio, Marchica Valentina, Dalla Palma Benedetta, Storti Paola, Toscani Denise, Vicario Emanuela, Malavasi Fabio, Novel targets for the treatment of relapsing multiple myeloma, Expert Review of Hematology, 12, 7, 2019. Crossref
-
Karpinski Pawel, Rossowska Joanna, Sasiadek Maria Malgorzata, Immunological landscape of consensus clusters in colorectal cancer, Oncotarget, 8, 62, 2017. Crossref
-
Dong Zhaocheng, Liu Zhiyuan, Dai Haoran, Liu Wenbin, Feng Zhendong, Zhao Qihan, Gao Yu, Liu Fei, Zhang Na, Dong Xuan, Zhou Xiaoshan, Du Jieli, Huang Guangrui, Tian Xuefei, Liu Baoli, Asmann Charles Elias, The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy, Journal of Immunology Research, 2020, 2020. Crossref
-
Iannazzo Daniela, Ettari Roberta, Giofrè Salvatore, Eid Ali H., Bitto Alessandra, Recent Advances in Nanotherapeutics for Multiple Myeloma, Cancers, 12, 11, 2020. Crossref
-
Shah Nina, Aiello Jack, Avigan David E, Berdeja Jesus G, Borrello Ivan M, Chari Ajai, Cohen Adam D, Ganapathi Karthik, Gray Lissa, Green Damian, Krishnan Amrita, Lin Yi, Manasanch Elisabet, Munshi Nikhil C, Nooka Ajay K, Rapoport Aaron P, Smith Eric L, Vij Ravi, Dhodapkar Madhav, The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma, Journal for ImmunoTherapy of Cancer, 8, 2, 2020. Crossref
-
Danielewicz Hanna, Gurgul Artur, Dębińska Anna, Myszczyszyn Grzegorz, Szmatoła Tomasz, Myszkal Anna, Jasielczuk Igor, Drabik-Chamerska Anna, Hirnle Lidia, Boznański Andrzej, Maternal atopy and offspring epigenome-wide methylation signature, Epigenetics, 16, 6, 2021. Crossref
-
Leow Christopher Chang-Yew, Low Michael Sze Yuan, Targeted Therapies for Multiple Myeloma, Journal of Personalized Medicine, 11, 5, 2021. Crossref
-
Yu Bo, Jiang Tianbo, Liu Delong, BCMA-targeted immunotherapy for multiple myeloma, Journal of Hematology & Oncology, 13, 1, 2020. Crossref
-
Matson Erik M., Abyazi Miranda L., Bell Kayla A., Hayes Kevin M., Maglione Paul J., B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease, Frontiers in Immunology, 11, 2021. Crossref
-
Allegra Alessandro, Gioacchino Mario Di, Tonacci Alessandro, Petrarca Claudia, Gangemi Sebastiano, Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective, Nanomaterials, 11, 11, 2021. Crossref
-
Hu Shanshan, Wang Rui, Zhang Mei, Liu Kangkang, Tao Juan, Tai Yu, Zhou Weijie, Wang Qingtong, Wei Wei, BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway, Biomedicine & Pharmacotherapy, 114, 2019. Crossref
-
Mikkilineni Lekha, Kochenderfer James N., CAR T cell therapies for patients with multiple myeloma, Nature Reviews Clinical Oncology, 18, 2, 2021. Crossref
-
Feng Deming, Sun Jian, Overview of anti‐BCMA CAR‐T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma, Scandinavian Journal of Immunology, 92, 2, 2020. Crossref
-
Hosny Mashhour, Verkleij Christie P. M., van der Schans Jort, Frerichs Kristine A., Mutis Tuna, Zweegman Sonja, van de Donk Niels W. C. J., Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma, Journal of Clinical Medicine, 10, 19, 2021. Crossref
-
Hammood Manar, Craig Andrew, Leyton Jeffrey, Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development, Pharmaceuticals, 14, 7, 2021. Crossref
-
Boothby Mark R., Hodges Emily, Thomas James W., Molecular regulation of peripheral B cells and their progeny in immunity, Genes & Development, 33, 1-2, 2019. Crossref
-
Tremblay Patricia G., Fortin Chloé, Sirard Marc-André, Gene cascade analysis in human granulosa tumor cells (KGN) following exposure to high levels of free fatty acids and insulin, Journal of Ovarian Research, 14, 1, 2021. Crossref
-
Tian Zheng, Liu Ming, Zhang Ya, Wang Xin, Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies, Journal of Hematology & Oncology, 14, 1, 2021. Crossref
-
Carrillo-Ballesteros F. J., Palafox-Sánchez C. A., Franco-Topete R. A., Muñoz-Valle J. F., Orozco-Barocio G., Martínez-Bonilla G. E., Gómez-López C. E., Marín-Rosales M., López-Villalobos E. F., Luquin S., Castañeda-Chávez A., Oregon-Romero Edith, Expression of BAFF and BAFF receptors in primary Sjögren’s syndrome patients with ectopic germinal center-like structures, Clinical and Experimental Medicine, 20, 4, 2020. Crossref
-
Simón Rocío, Díaz-Rosales Patricia, Tafalla Carolina, The Ancient Cytokine BAFF- and APRIL-like Molecule Regulates the Functionality of Teleost IgM+ B Cells Similarly to BAFF and APRIL, The Journal of Immunology, 206, 8, 2021. Crossref
-
Shin Charles, Kim Sung Soo, Jo Yong Hwa, Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications, Molecular Therapy - Oncolytics, 22, 2021. Crossref
-
Swan Dawn, Routledge David, Harrison Simon, The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies, British Journal of Haematology, 196, 3, 2022. Crossref
-
Chen Zhaochun, Diaz Giacomo, Pollicino Teresa, Zhao Huaying, Engle Ronald E., Schuck Peter, Shen Chen-Hsiang, Zamboni Fausto, Long Zhifeng, Kabat Juraj, De Battista Davide, Bock Kevin W., Moore Ian N., Wollenberg Kurt, Soto Cinque, Govindarajan Sugantha, Kwong Peter D., Kleiner David E., Purcell Robert H., Farci Patrizia, Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure, Proceedings of the National Academy of Sciences, 115, 48, 2018. Crossref
-
Guo Ruiting, Lu Wenyi, Zhang Yi, Cao Xinping, Jin Xin, Zhao Mingfeng, Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting, Frontiers in Immunology, 13, 2022. Crossref
-
Topp Max S., Duell Johannes, Zugmaier Gerhard, Attal Michel, Moreau Philippe, Langer Christian, Krönke Jan, Facon Thierry, Salnikov Alexey V., Lesley Robin, Beutner Karl, Kalabus James, Rasmussen Erik, Riemann Kathrin, Minella Alex C., Munzert Gerd, Einsele Hermann, Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma, Journal of Clinical Oncology, 38, 8, 2020. Crossref
-
Quazi Sameer, An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy, Clinical Lymphoma Myeloma and Leukemia, 22, 6, 2022. Crossref
-
Maus Marcela V., June Carl H., Zoom Zoom: Racing CARs for Multiple Myeloma, Clinical Cancer Research, 19, 8, 2013. Crossref
-
Nobari Shirin Teymouri, Nojadeh Jafar Nouri, Talebi Mehdi, B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages, Journal of Translational Medicine, 20, 1, 2022. Crossref
-
Lancman Guido, Sastow Dahniel L., Cho Hearn J., Jagannath Sundar, Madduri Deepu, Parekh Samir S., Richard Shambavi, Richter Joshua, Sanchez Larysa, Chari Ajai, Bispecific Antibodies in Multiple Myeloma: Present and Future, Blood Cancer Discovery, 2, 5, 2021. Crossref
-
Ndacayisaba Libere J., Rappard Kate E., Shishido Stephanie N., Setayesh Sonia M., Tang Guilin, Lin Pei, Matsumoto Nicholas, Hsu Ching-Ju, Nevarez Rafael, Velasco Carmen Ruiz, Naghdloo Amin, Yang Eric, Kelly Kevin, Hicks James, Mason Jeremy, Orlowski Robert Z., Manasanch Elisabet E., Kuhn Peter, Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms, International Journal of Molecular Sciences, 23, 21, 2022. Crossref